A number of genetic mutations have recently been identified that appear to be important in the development of pancreatitis. Point mutations in the cationic trypsinogen gene are capable of initiating pancreatitis. These mutations also provide important insights into the pathophysiology of acute pancreatitis and into potential connections between acute and chronic pancreatitis. Mutations in the genes encoding for the pancreatic secretory trypsin inhibitor and the cystic fibrosis transmembrane conductance regulator more likely work in concert with other genes and environmental factors in affecting disease susceptibility. Although the subject so far has recieved only a limited amount of study, genetic polymorphisms in a wide range of genes relating to pancreatic function and to regulation of inflammation are likely to play major roles in determining each individual’s susceptibility to developing pancreatitis, and its severity if it does develop.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 10.Teich N, Bauer N, Mössner J, Keim V: Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants. Am J Gastroenterol 2002, 97:341–346. In this study, the N346 mutation in SPINK 1 is the most frequent genetic risk factor for idiopathic pancreatitis. Three novel mutations found in the cationic trypsinogen gene are of uncertain significance.PubMedGoogle Scholar
- 26.Schneider A, Suman A, Rossi L, et al.: SPINK 1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Gastroenterology 2002, 123:1026–1030. The N34S mutation in SPINK 1 is strongly associated with tropical calcific pancreatitis and fibrocalculous pancreatic diabetes.PubMedCrossRefGoogle Scholar
- 27.Hassan Z, Mohan V, Ali L, et al.: SPINK 1 is a susceptibility gene for fibrocalculous pancreatic diabetes in subjects from the Indian subcontinent. Am J Hum Genet 2002, 71:964–968. This report provides further evidence of a strong association between the N34S SPINK 1 mutation and tropical pancreatitis.PubMedCrossRefGoogle Scholar
- 30.Noone PG, Zhou Z, Silverman LM, et al.: Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001, 121:1310–1319. The combination of two CFTR mutations and an N34S SPINK 1 mutation raises the risk of pancreatitis 900-fold.PubMedCrossRefGoogle Scholar
- 31.Powell JJ, Fearon KCH, Siriwardena AK, Ross JA: Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery 2001, 129:633–640. No differences in the frequencies of polymorphisms were found between patients with pancreatitis and healthy control subjects for genes involved in regulating the systemic inflammatory response.PubMedCrossRefGoogle Scholar
- 34.Teich N, Walther K, Bodeker H, et al.: Relevance of variants in serum antiproteinases for the course of chronic pancreatitis. Scand J Gastroenterol 2002, 37:360–365. This study suggests that variants in α-1-antitrypsin may have some moderating effect on the course of chronic nonalcoholic pancreatitis.PubMedCrossRefGoogle Scholar